Jame Abraham, Enterprise Chairman and Professor at the Department of Hematology and Medical Oncology at Cleveland Clinic, shared a post on X:
“Use of Vaginal Estrogen in Breast and Gynecologic Cancer Survivors, JCO Oncology Practice. In selected patients with refractory symptoms low dose vaginal estrogen could be effective!”
Title: Use of Vaginal Estrogen in Breast and Gynecologic Cancer Survivors
Authors: Jersey B. Burns, Mariam M. AlHilli, Azka Ali, Erin Roesch, Deepanjana Das
You may also be interested in: Vaginal Estrogen After Breast Cancer: New Review Supports Low-Dose Therapy for Refractory GSM, with Important Caution for Aromatase Inhibitor Users
